Aberrant activation of androgen receptor in a new neuropeptide-autocrine model of androgen-insensitive prostate cancer

Tekijä Yang, Joy C., Ok, Joon-ha, Busby, J. Erik, Borowsky, Alexander D., Kung, Hsing-Jien, Evans, Christopher P.
Julkaistu 2009

ABILITY OF CLINICAL GRADE TO PREDICT FINAL PATHOLOGIC STAGE IN UPPER URINARY TRACT TRANSITIONAL CELL CARCINOMA: IMPLICATIONS FOR THERAPY

Tekijä BROWN, GORDON A., MATIN, SURENA F., BUSBY, J. ERIK, DINNEY, COLIN P. N., GROSSMAN, H. BARTON, PETTAWAY, CURTIS A., MUNSELL, MARK F., KAMAT, ASHISH M.
Julkaistu 2007

Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer?

Tekijä Wei, John T., Feng, Ziding, Partin, Alan W., Brown, Elissa, Thompson, Ian, Sokoll, Lori, Chan, Daniel W., Lotan, Yair, Kibel, Adam S., Busby, J. Erik, Bidair, Mohamed, Lin, Daniel W., Taneja, Samir S., Viterbo, Rosalia, Joon, Aron Y., Dahlgren, Jackie, Kagan, Jacob, Srivastava, Sudhir, Sanda, Martin G.
Julkaisussa J Clin Oncol (2014)

A Phase 2 Cancer Chemoprevention Biomarker Trial of Isoflavone G-2535 (Genistein) in Presurgical Bladder Cancer Patients

Tekijä Messing, Edward, Gee, Jason R., Saltzstein, Daniel R., Kim, KyungMann, diSant’Agnese, Anthony, Kolesar, Jill, Harris, Linda, Faerber, Adrienne, Havighurst, Thomas, Young, Jay M., Efros, Mitchell, Getzenberg, Robert H., Wheeler, Marcia A., Tangrea, Joseph, Parnes, Howard, House, Margaret, Busby, J. Erik, Hohl, Raymond, Bailey, Howard
Julkaistu 2012